AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
iShares Core Dividend Growth ETF (DGRO): How to Buy
2 Dividend Stocks to Double Up on Right Now
These two companies can help you sleep easy at night.
The Largest Healthcare Companies by Market Cap in October 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
Carolina Wealth Trims It's AbbVie Stake to Nearly Nothing
Why AbbVie Stock Soared in September
It was a month stuffed with several different kinds of wins for the pharmaceutical company.
How to Invest in Vanguard Health Care ETF (VHT)
St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy
SPDR S&P Biotech ETF (XBI): How to Buy
Valuation
Earnings Transcripts
AbbVie (ABBV) Q2 2025 Earnings Call Transcript
None
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2024.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.